how to.use peptides FAQ

Mild redness lasting less than 24 hours is normal. Subcutaneous injection causes localized inflammatory response as the immune system processes the foreign protein. Persistent swelling beyond 48 hours, warmth, or purulent discharge indicates bacterial infection from contaminated peptide solution or non-sterile injection technique. Discontinue injections from that vial immediately, consult a physician, and evaluate your reconstitution and injection sterilization protocols. Injection site reactions occur in 5–10% of peptide administrations and typically resolve with improved technique. Alcohol-swabbing the stopper before every draw, using fresh needles for each injection, and rotating sites daily eliminate most reactions.

Discard it immediately. Cloudiness indicates bacterial contamination or protein aggregation from improper storage. Peptides in solution should be completely clear and colorless. Aggregated proteins form insoluble clumps that not only lose therapeutic activity but can trigger immune responses when injected. Contaminated vials introduce infection risk that far outweighs any cost savings from attempting to salvage the dose. Cloudiness from refrigeration-induced precipitation (some peptides crystallize when cold) disappears within 5–10 minutes at room temperature. If it doesn't, the vial is compromised.

Resume at the next scheduled time without doubling the dose. Peptide protocols depend on sustained signaling rather than cumulative dose. Missing a single injection of BPC-157 or TB-500 doesn't reset healing progress, but consistently irregular dosing prevents plasma levels from stabilizing, reducing efficacy by 20–30%. For long-half-life peptides like TB-500 (7–10 days), a missed weekly dose can be administered up to 3 days late without compromising the protocol. Short-half-life peptides like BPC-157 (4–6 hours) require twice-daily consistency to maintain therapeutic receptor activation.